TLT will get BTDwe will get BTD
if certain criteria are met, which the FDA previously defined to the Company for BTD as clinical data on approximately 20 to 25 patients enrolled and provided the primary Study Procedure, who demonstrate significant safety and efficacy clinical outcomes. To this list, the FDA has added: Post Study II Monitoring of Response and Central Pathology Laboratory Review, as further defined above.
FDA approved all kind of garbage with fuge side affects.
Let's hope that Kennedy will clean up this mess.